Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial cancer and various other cancers, and is caused by a mutation in one of the mismatch repair genes: MLH1, MSH2, MSH6 or PMS2. In 2007, a group of European experts (the Mallorca group) published guidelines for the clinical management of LS. Since then substantial new information has become available necessitating an update of the guidelines. In 2011 and 2012 workshops were organised in Palma de Mallorca. A total of 35 specialists from 13 countries participated in the meetings. The first step was to formulate important clinical questions. Then a systematic literature search was performed using the Pubmed database and manual searches of relevant articles. During the workshops the outcome of the literature search was discussed in detail. The guidelines described in this paper may be helpful for the appropriate management of families with LS. Prospective controlled studies should be undertaken to improve further the care of these families.

[1]  W. Frankel,et al.  Mismatch Repair Protein Deficiency is Common in Sebaceous Neoplasms and Suggests the Importance of Screening for Lynch Syndrome , 2013, The American Journal of dermatopathology.

[2]  M. Woods,et al.  Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation , 2013, Clinical genetics.

[3]  J. Kleibeuker,et al.  Dietary patterns and colorectal adenomas in Lynch syndrome , 2013, Cancer.

[4]  J. Stockman,et al.  Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer: A Cost-Effectiveness Analysis , 2013 .

[5]  S. Stucklessa,et al.  Impact of gynecological screening in Lynch syndrome carriers with an MSH 2 mutation , 2013 .

[6]  The spectrum of urological malignancy in Lynch syndrome , 2013, Familial Cancer.

[7]  Markus Loeffler,et al.  Risks of less common cancers in proven mutation carriers with lynch syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Bishop,et al.  Edinburgh Research Explorer Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer , 2022 .

[9]  M. Woods,et al.  Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation , 2012, Clinical genetics.

[10]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[11]  H. Vasen,et al.  Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?--A systematic review. , 2012, Critical reviews in oncology/hematology.

[12]  J. Mecklin,et al.  Causes of death of mutation carriers in Finnish Lynch syndrome families , 2012, Familial Cancer.

[13]  E. Dekker,et al.  Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy , 2012, Diseases of the colon and rectum.

[14]  R. Scott,et al.  8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome , 2012, European Journal of Human Genetics.

[15]  E. Kuipers,et al.  Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. , 2012, Gynecologic oncology.

[16]  S. Ballereau,et al.  Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals , 2012, Gut.

[17]  E. Kuipers,et al.  Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome , 2012, The Journal of pathology.

[18]  F. Chan,et al.  Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice. , 2012, Best practice & research. Clinical gastroenterology.

[19]  Aung Ko Win,et al.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Kleibeuker,et al.  Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. , 2012, Gastroenterology.

[21]  G. Marra,et al.  Evidence for breast cancer as an integral part of lynch syndrome , 2012, Genes, chromosomes & cancer.

[22]  Rodney J Scott,et al.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial , 2011, The Lancet.

[23]  A. Duval,et al.  Screening for Lynch Syndrome in Colorectal Cancer: Are We Doing Enough? , 2012, Annals of Surgical Oncology.

[24]  Á. Carracedo,et al.  Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer , 2011, Gut.

[25]  I. Bernstein,et al.  Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study , 2011, Familial Cancer.

[26]  Laetitia Huiart,et al.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.

[27]  H. Grönberg,et al.  Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. , 2011, Gynecologic oncology.

[28]  J. Garber,et al.  Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch Syndrome , 2011, Familial Cancer.

[29]  Aung Ko Win,et al.  Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes , 2011, British Journal of Cancer.

[30]  A. Caughey,et al.  A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families , 2011, Familial Cancer.

[31]  A. Auranen,et al.  A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families , 2011, Acta obstetricia et gynecologica Scandinavica.

[32]  H. Vasen,et al.  Cancer: Lynch syndrome—how should colorectal cancer be managed? , 2011, Nature Reviews Gastroenterology &Hepatology.

[33]  T. Frebourg,et al.  Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers , 2011, European Journal of Human Genetics.

[34]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[35]  S. Haque.  Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed. , 2011 .

[36]  J. Stockman,et al.  Risk of Pancreatic Cancer in Families With Lynch Syndrome , 2011 .

[37]  A. Milbourne,et al.  Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. , 2011, Journal of oncology practice.

[38]  Julie O. Culver,et al.  Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. , 2011, The Lancet. Oncology.

[39]  J. Mecklin,et al.  Sharing genetic risk with next generation: mutation-positive parents’ communication with their offspring in Lynch Syndrome , 2011, Familial Cancer.

[40]  Aung Ko Win,et al.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery , 2010, Gut.

[41]  J. Hendriks,et al.  Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Heresbach,et al.  Small-bowel capsule endoscopy diagnoses early and advanced neoplasms in asymptomatic patients with Lynch syndrome. , 2010, Endoscopy.

[43]  L. Kiemeney,et al.  Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers , 2010, Journal of Medical Genetics.

[44]  E. Dekker,et al.  One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. , 2010, Gastroenterology.

[45]  J. Potter,et al.  Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center , 2010, Clinical Cancer Research.

[46]  Finlay Macrae,et al.  Risks of Lynch syndrome cancers for MSH6 mutation carriers. , 2010, Journal of the National Cancer Institute.

[47]  M. Kloor,et al.  Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[48]  Hester F. Lingsma,et al.  Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. , 2010, Gastroenterology.

[49]  R. Broaddus,et al.  Primary Peritoneal Cancer After Bilateral Salpingo-Oophorectomy in Two Patients With Lynch Syndrome , 2010, Obstetrics and gynecology.

[50]  Heather Hampel,et al.  The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer , 2010, Genetics in Medicine.

[51]  J. Dungan.  Lynch Syndrome Screening Strategies Among Newly Diagnosed Endometrial Cancer Patients , 2010 .

[52]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[53]  P. Møller,et al.  Recommendations to improve identification of hereditary and familial colorectal cancer in Europe , 2010, Familial Cancer.

[54]  U. Jensen,et al.  Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome , 2010, Breast Cancer Research and Treatment.

[55]  T. Clancy.  A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions , 2010, Familial Cancer.

[56]  P. Peltomäki,et al.  Molecular Analysis of Endometrial Tumorigenesis: Importance of Complex Hyperplasia Regardless of Atypia , 2009, Clinical Cancer Research.

[57]  P. Møller,et al.  Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[58]  P. Møller,et al.  Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds , 2009, Journal of Medical Genetics.

[59]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[60]  D. Evans,et al.  Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study , 2009, Familial Cancer.

[61]  L. Massuger,et al.  Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome , 2009, Familial Cancer.

[62]  L. Vatten,et al.  Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population‐based study , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[63]  D. Evans,et al.  Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.

[64]  Z. Szentirmay,et al.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome , 2009, Human mutation.

[65]  S. Manekeller.  Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome , 2009 .

[66]  R. Houlston,et al.  Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. , 2009, Gastroenterology.

[67]  Feng Yang,et al.  Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. , 2009, The New England journal of medicine.

[68]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[69]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  F. Radvanyi,et al.  Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening , 2008, The American Journal of Gastroenterology.

[71]  Jean L. Jenkins,et al.  Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study , 2008, Psycho-oncology.

[72]  J. Mecklin,et al.  The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.

[73]  J. Kwon,et al.  Cost‐effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome , 2008, Cancer.

[74]  I. Bernstein,et al.  Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer , 2008, Familial Cancer.

[75]  Brenda Wilson,et al.  A systematic review of perceived risks, psychological and behavioral impacts of genetic testing , 2008, Genetics in Medicine.

[76]  P. Laurent-Puig,et al.  Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study , 2007, International Journal of Gynecologic Cancer.

[77]  Esa Läärä,et al.  Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. , 2007, Gastroenterology.

[78]  N. Aaronson,et al.  Colorectal Cancer in the Family: Psychosocial Distress and Social Issues in the Years Following Genetic Counselling , 2007, Hereditary cancer in clinical practice.

[79]  F. Nagengast,et al.  Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[80]  O. Ukoumunne,et al.  The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing , 2007, Genetics in Medicine.

[81]  S. Duffy,et al.  Does a “one-stop” gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health? , 2007, International Journal of Gynecologic Cancer.

[82]  A. Cats,et al.  Is surveillance of the small bowel indicated for Lynch syndrome families? , 2007, Gut.

[83]  P. Møller,et al.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.

[84]  J. Mecklin,et al.  Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome , 2007, International journal of cancer.

[85]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[86]  N. Aaronson,et al.  The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  J. Kleibeuker,et al.  Decrease in mortality in Lynch syndrome families because of surveillance. , 2006, Gastroenterology.

[88]  M. Munsell,et al.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.

[89]  H. Stähelin.  Guidelines , 1994, Communicating Science.

[90]  H. Meijers-Heijboer,et al.  Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures , 2005, Familial Cancer.

[91]  E. Legius,et al.  Predictive Genetic Testing for Hereditary Breast and Ovarian Cancer: Psychological Distress and Illness Representations 1 Year Following Disclosure , 2005, Journal of Genetic Counseling.

[92]  N. Aaronson,et al.  Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  Eero Pukkala,et al.  Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. , 2005, Gastroenterology.

[94]  H C van Houwelingen,et al.  Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.

[95]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[96]  M. Nooij,et al.  Survival of Patients with Ovarian Cancer due to a Mismatch Repair Defect , 2005, Familial Cancer.

[97]  J. Mecklin,et al.  Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families , 2005, Familial Cancer.

[98]  H. Lynch,et al.  Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). , 2004, Archives of internal medicine.

[99]  B. Meiser,et al.  Psychological impact of genetic testing for hereditary non‐polyposis colorectal cancer , 2004, Clinical genetics.

[100]  Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma , 2004, Cancer.

[101]  B. Nilsson,et al.  Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[103]  A. Lindblom,et al.  Evaluation of Psychosocial Effects of Pre-Symptomatic Testing for Breast/Ovarian and Colon Cancer Pre-Disposing Genes: A 12-Month Follow-Up , 2004, Familial Cancer.

[104]  H. Hollema,et al.  Gynecologic screening in hereditary nonpolyposis colorectal cancer. , 2003, Gynecologic oncology.

[105]  L. Cassidy,et al.  The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening. , 2003, American journal of industrial medicine.

[106]  J. Kleibeuker,et al.  Surveillance for Hereditary Nonpolyposis Colorectal Cancer , 2002 .

[107]  J. Kleibeuker,et al.  Surveillance for Hereditary Nonpolyposis Colorectal Cancer: A Long-Term Study on 114 Families , 2002, Diseases of the colon and rectum.

[108]  D. Voskuil,et al.  Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. , 2002, European journal of cancer.

[109]  G. Kenter,et al.  The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma , 2002, Cancer.

[110]  L. Aaltonen,et al.  No Support for Endoscopic Surveillance for Gastric Cancer in Hereditary Non-Polyposis Colorectal Cancer , 2002, Scandinavian journal of gastroenterology.

[111]  W. Zoller,et al.  [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. , 2001, Zeitschrift fur Gastroenterologie.

[112]  P. Møller,et al.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  R. Hurst,et al.  Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. , 2001, Journal of the National Cancer Institute.

[114]  S. Gallinger,et al.  Motivations and psychosocial impact of genetic testing for HNPCC. , 2001, American journal of medical genetics.

[115]  J. Mecklin,et al.  Psychological consequences of predictive genetic testing for hereditary non‐polyposis colorectal cancer (HNPCC): A prospective follow‐up study , 2001, International journal of cancer.

[116]  H. Morreau,et al.  Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? , 2001, American journal of human genetics.

[117]  R. Scott,et al.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.

[118]  Y. Yuasa.  [Hereditary nonpolyposis colorectal cancer]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[119]  J. Wijnen,et al.  Gene‐environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing , 1999, International journal of cancer.

[120]  H T Lynch,et al.  Genetic testing in families with hereditary nonpolyposis colon cancer. , 1999, JAMA.

[121]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[122]  L. Aaltonen,et al.  Features of gastric cancer in hereditary non‐polyposis colorectal cancer syndrome , 1997, International journal of cancer.

[123]  P. Sistonen,et al.  Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. , 1995, Gastroenterology.

[124]  H. Lynch,et al.  Extracolonic cancer in hereditary nonpolyposis colorectal cancer. , 1993, Cancer.

[125]  L. Leviton,et al.  A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[126]  B. Armstrong,et al.  Bladder cancer screening among primary aluminum production workers in Quebec. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[127]  H. Lynch,et al.  Cancer family “G” revisited: 1895‐1970 , 1971, Cancer.

[128]  M. Shaw,et al.  Hereditary factors in cancer. Study of two large midwestern kindreds. , 1966, Archives of internal medicine.

[129]  A. S. Warthin.  HEREDITY WITH REFERENCE TO CARCINOMA: AS SHOWN BY THE STUDY OF THE CASES EXAMINED IN THE PATHOLOGICAL LABORATORY OF THE UNIVERSITY OF MICHIGAN, 1895-1913 , 1913 .

[130]  W J Macdonald,et al.  GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.